With fewer Part D plans and a $2,000 out-of-pocket cap, beneficiaries must rethink their Medicare drug coverage for 2025.

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...

Changes to Medicare in 2025 include a cap on out-of-pocket prescription drug costs, changes to mental health care services, ...

Robert Powell: Are you about to enroll in Medicare and trying to decide whether to sign up for a Medicare Advantage plan or ...

Medicare's star ratings system also accounts for enrollee turnaround. A plan that loses a lot of members in a given year will ...

Some health care provider networks in Minnesota have announced they will no longer accept specific Medicare Advantage plans ...

A record-low number of Medicare Part D plans could cause greater Medicare Advantage enrollment, which may not be a good thing ...

The feds say Dr. Rajesh Bindal lied about surgeries he never performed at Texas Spine & Neurosurgery Center P.A. on the ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...